SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-21-008184
Filing Date
2021-01-13
Accepted
2021-01-13 16:42:28
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 d90820d425.htm 425 22996
2 GRAPHIC g90820logo1.jpg GRAPHIC 5359
3 GRAPHIC g90820logo2.jpg GRAPHIC 4234
  Complete submission text file 0001193125-21-008184.txt   38121
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Subject) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-38533 | Film No.: 21526488
SIC: 2834 Pharmaceutical Preparations

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filed by) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations